| Literature DB >> 18366800 |
Arielle Lasry1, Michael W Carter, Gregory S Zaric.
Abstract
BACKGROUND: HIV/AIDS resource allocation decisions are influenced by political, social, ethical and other factors that are difficult to quantify. Consequently, quantitative models of HIV/AIDS resource allocation have had limited impact on actual spending decisions. We propose a decision-support System for HIV/AIDS Resource Allocation (S4HARA) that takes into consideration both principles of efficient resource allocation and the role of non-quantifiable influences on the decision-making process for resource allocation.Entities:
Year: 2008 PMID: 18366800 PMCID: PMC2386442 DOI: 10.1186/1478-7547-6-7
Source DB: PubMed Journal: Cost Eff Resour Alloc ISSN: 1478-7547
Figure 1The 4 steps of S4HARA.
HIV/AIDS program utilization at the kwaDukuza PHC clinic (Y2004)
| HIV/AIDS program | 2004 annual estimate (Supplied by iLembe District Health office) | |
| VCT | Number of patients counseled | 1,728 |
| Number of patients counselled & tested | 1,587 | |
| Number of patients tested HIV positive | 897 | |
| ART | Number of patients with clinical AIDS | 7,364 |
| Number of patients referred for ART | 180 | |
| Number of patients in ART program (administered outside clinic) | 540 | |
| Condom | Condom packages picked up | 4,664 |
| Wellness (Annual estimate based on 6 months of data) | Number of patients seen | 4,880 |
| CD4 cell count tests | 724 | |
| Patients with CD4 cell count <200 | 276 | |
| Treatment of STIs | Number of patients seen for STIs | 4,741 |
| STIs treated (new episode) | 3,203 | |
| STI partner notification slips issued | 4,288 | |
| PMTCT (Annual estimate based on 9 months of data) | Number of patients counselled | 2,840 |
| Number of patients counselled & tested | 2,540 | |
| Number patients tested HIV positive | 1,056 | |
| Number of patients given nevirapine | 732 | |
Figure 2Initial blank screen of an influence diagram.
Figure 3Positive influence arc.
Figure 4Adding arcs to create an influence diagram.
Figure 5Finalized influence diagram.
Figure 6Priority setting as the approach used in Step 3.
Figure 7Equity as the approach used in Step 3.
HIV/AIDS program cost per DALY saved as reported in the literature (US$ 2004)
| HIV/AIDS cost-effectiveness studies | |||||
| HIV/AIDS program | Hogan (2005) | Creese (2002) | Badri (2006) | Marseille (2002) | Average cost per DALY saved |
| VCT | $89.97 | $21.16 | - | - | $55.56 |
| PMTCT | $37.30 | $7.72 | - | - | $22.51 |
| Treatment of STIs | $20.85 | $13.49 | - | - | $17.17 |
| ART | - | - | $01 | $370.20 | $185.10 |
| Wellness | - | $6.48 | - | - | $6.48 |
| Condom distribution2 | - | - | - | - | $4.60 |
1 We used a value of zero because Badri et al. (2006) report that ART is cost-saving relative to a "no intervention" comparator (no-ART). According to this study, the yearly cost per person of a patient on ART is $1513 while is it $3520 for no-ART due to increased medical costs associated with the treatment of opportunistic infections. Further, the number of survival days is 1120 for a patient on ART and 510 days when a patient is not on ART. The resulting incremental cost-effectiveness ratio is negative indicating that ART is both less expensive and more effective than no-ART.
2 The cost per DALY saved for the condom distribution program is calculated by translating an averted infection into DALYs gained.
Figure 8Optimization as the approach used in Step 3.
Unit costs of HIV/AIDS programs
| Condom distribution | Cost per male condom distributed | $0.12 |
| Treatment of STIs | Cost per STI treated in clinic | $11.40 |
| VCT | Cost per person counselled and tested | $21.61 |
| PMTCT | Cost per woman screened | $8.00 |
| Cost of ARV regimen per woman testing HIV+ | $10.00 | |
| Cost per woman of six months of infant formula | $69.60 | |
| ART | ARV first line (per patient yearly cost) | $449.00 |
| Labs for ARV monitoring (per patient yearly cost) | $16.00 | |
| Wellness | Prophylaxis of OIs (per patient yearly cost) | $71.00 |
| Treatment of OIs (per patient yearly cost) | $415.00 | |
Figure 9Sensitivity analysis on Optimization as the approach used in Step 3.
Figure 10Barriers and facilitators.
2004 Estimated annual HIV/AIDS program budget at the kwaDukuza PHC clinic
| HIV/AIDS Program | Program utilization rate | 2004 estimate3 | Program unit costs [41] | Current annual spending |
| Condoms | Number of condoms distributed | 46,640 | $0.12 | $5,597 |
| Treatment of STIs | Number of patients seen for STIs | 4,741 | $11.40 | $54,047 |
| VCT | Number of patients counselled | 1,728 | $21.61 | $37,342 |
| PMTCT | Number of patients counselled | 2,840 | $20.994 | $59,617 |
| ART | Number of patients on ART | 540 | $465.00 | $251,100 |
| Wellness | Number of distinct patients seen5 | 2,440 | $126.326 | $308,220 |
| Total HIV/AIDS program spending | $715,923 | |||
3 2004 data supplied by the iLembe District Health office
4 Of the total number of patients counseled and tested for PMTCT, 29% received a regimen of Nevirapine, see Table 1. According to a clinic nurse in charge of the PMTCT program, the uptake of infant formula is 50%; the remaining women are advised to breastfeed exclusively for 6 months. Therefore, the unit cost for PMTCT is: (8.00 + (0.29*10.00) + (0.29*0.50*69.60)) = $20.99
5 In 2004, there were a total of 124,281 visits to the kwaDukuza PHC but the population targeted by the clinic is estimated at approximately 61,000. Therefore each person in the target region visited the clinic an average of two times in the year 2004. Further, 4,880 patients were seen in the wellness program in 2004, see Table 1. The unit costs for wellness in Table 3 are estimated on a per patient basis; thus we refer to the number of distinct patients seen in the wellness program (4880 visits ÷ 2 visits per patient = 2440 distinct patients).
6 The unit cost of treatment of OIs in Table 3 is estimated on a per patient lifetime basis. We assume the average number of life years remaining is 7.5 years. Therefore the yearly unit cost of the wellness program is: (71.00 + (415 ÷ 7.5)) = $126.32
2004/2005 HIV/AIDS budget for the province of kwaZulu-Natal (KZN)
| HIV/AIDS budget 2004–05 (×1000 2004 US$) | |
| KZN Department of Health | $54,125 [47] |
| KZN Department of Education | $4,504 [48] |
| KZN Department Social welfare | $2,024 [47] |
| Foreign assistance (Global Fund) | $10,549 [47] |
| Total | $71,202 |
Maximum annual allocation to HIV/AIDS programs
| HIV/AIDS Program | Maximum Allocation | Data and assumptions (Data supplied by the iLembe District Health office) |
| Condoms | $106,782 | In 2004, there were approximately 88,985 visits the kwaDukuza PHC clinic by people over the age of 15. Condoms are distributed in packages of ten. |
| Treatment of STIs | $379,650 | STI prevalence rate is 38% [46]. We assume an average of two STI recurrences per patient per year. |
| VCT | $473,466 | The 15 and older population targeted by the clinic is 43,820 and we assume that at best they are tested for HIV on a biennial basis. |
| PMTCT | $113,145 | In 2004, 2840 women were counseled. We assume the conversion rate from counseling to test can be increased is 100%. We assume that all women who test positive (40%) are treated with Nevirapine and offered infant formula. |
| ART | $1,791,716 | The 15 and older population targeted by the clinic is 43,820 and 40% of them are HIV positive (HIV+). The size of the 0–15 population targeted by the clinic is 17,380 and we assume that 10% of them are HIV+. We assume that 20% of those HIV+ have AIDS and qualifies for ART. |
| Wellness | $1,216,821 | We assume that 50% of the HIV + population in kwaDukuza PHC catchment area can benefit from the wellness program. |